Skip to content

Efficacy of programmed intermittent bolus compared to continuous infusion in combination with patient-controlled epidural analgesia for postoperative pain management after pylorus-preserving pancreaticoduodenectomy

Efficacy of programmed intermittent bolus compared to continuous infusion in combination with patient-controlled epidural analgesia for postoperative pain management after pylorus-preserving pancreaticoduodenectomy - PIB in combination with PCEA

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019777
Enrollment
40
Registered
2015-11-16
Start date
2014-01-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Patients were assigned as a delivery method to 2 groups. Group P(programed intermittent bolus
4 or 6 ml every 60 min, PCA bolus
3 ml, lock out time
30 min) dose of intermittent bolus HT &lt
155 cm
4 ml HT &gt
6 ml HT: height Group C (continuous infusion
4 or 6 ml/h, PCA bolus
30 min) rate of continuous dose HT &lt
4 ml/h HT &gt
6 ml/h HT: height

Sponsors

Sapporo Medical University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists physical status I or II Patients were scheduled for elective pylorus-preserving pancreaticoduodenectomy (PPPD) under epidural block and general anesthesia

Exclusion criteria

Exclusion criteria: Patients with respiratory disorder Patients with heart failure Patients with anticoagulant therapy Patients with obesity(BMI > 35)

Design outcomes

Primary

MeasureTime frame
1) Pain intensity at rest and during movement at 0, 2, 4, , 8, 12 postoperatively 2) Dose of PCA bolus for 12 hours 3) Dose of supplemental analgesic for 12 hours

Secondary

MeasureTime frame
1) Hemodynamic data (heart rate, blood pressure)at 0, 2, 4, , 8, 12 postoperatively 2) Adverse effects for 12 hours 3) Patient's satisfaction at 12 hr postoperatively

Countries

Japan

Contacts

Public ContactYukitoshi Niiyama

Sapporo Medical University School of Medicine Department of Anesthesiology

niiyama@sapmed.ac.jp011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026